These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 37483533)

  • 1. Development and validation of a liquid chromatography tandem mass spectrometry method for the analysis of 53 benzodiazepines in illicit drug samples.
    Whitehead HD; Hayes KL; Swartz JA; Lieberman M
    Forensic Chem; 2023 Sep; 35():. PubMed ID: 37483533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated method for the analysis of 22 illicit drugs and their metabolites via liquid chromatography tandem mass spectrometry (LC-MS/MS) in illicit drug samples collected in Chicago, IL.
    Whitehead HD; Hayes KL; Swartz JA; Prete E; Robison-Taylor L; Mackesy-Amiti ME; Jimenez AD; Lieberman M
    Forensic Chem; 2023 May; 33():. PubMed ID: 36910306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
    Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
    J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine analysis by an improved LC-MS/MS method illustrates usage patterns in Washington State.
    Keung Chan K; Moore AJ; Hoofnagle AN; Baird GS; Liao HC
    Clin Chim Acta; 2023 Mar; 543():117274. PubMed ID: 36934953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development and Validation of a Novel Designer Benzodiazepines Panel by LC-MS-MS.
    Mastrovito RA; Papsun DM; Logan BK
    J Anal Toxicol; 2021 May; 45(5):423-428. PubMed ID: 33476376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens.
    Garland JM; Hull JD; Bender CL; Marshall L; Holt AC
    J Addict Med; 2022 May-Jun 01; 16(3):354-356. PubMed ID: 34172626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening suspect pharmaceuticals for illicit designer benzodiazepines using raman, SERS, and FT-IR prior to comprehensive analysis using LC-MS.
    Kimani MM; Smith SW; Lanzarotta A; Brueggemeyer JL; Batson JS
    Forensic Sci Int; 2022 Sep; 338():111390. PubMed ID: 35870307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A; Snyder ML; Ptolemy AS; Melanson S
    Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay.
    Glover SJ; Allen KR
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):111-7. PubMed ID: 19969595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine.
    Rossi B; Freni F; Vignali C; Stramesi C; Collo G; Carelli C; Moretti M; Galatone D; Morini L
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine.
    Pettersson Bergstrand M; Helander A; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1035():104-110. PubMed ID: 27697727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a fast ionic liquid-based dispersive liquid-liquid microextraction procedure combined with LC-MS/MS analysis for the quantification of benzodiazepines and benzodiazepine-like hypnotics in whole blood.
    De Boeck M; Missotten S; Dehaen W; Tytgat J; Cuypers E
    Forensic Sci Int; 2017 May; 274():44-54. PubMed ID: 28094153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Traditional and Designer Benzodiazepines in Urine through LC-MS/MS.
    Rossi B; Freni F; Carelli C; Moretti M; Galatone D; Vignali C; Morini L
    Curr Pharm Des; 2022; 28(32):2622-2638. PubMed ID: 36045516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases.
    Heide G; Høiseth G; Middelkoop G; Øiestad ÅML
    J Anal Toxicol; 2020 Dec; 44(8):905-914. PubMed ID: 32369173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analytical strategy for designer benzodiazepines and Z-hypnotics determination in plasma samples using ultra-high performance liquid chromatography/tandem mass spectrometry after microextraction by packed sorbent.
    Ares-Fuentes AM; Lorenzo RA; Fernández P; Carro AM
    J Pharm Biomed Anal; 2021 Feb; 194():113779. PubMed ID: 33279303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast and Sensitive Method for the Determination of 17 Designer Benzodiazepines in Hair by Liquid Chromatography-Tandem Mass Spectrometry.
    DeFreitas L; Fonseca Pego AM; Kronstrand R; Lendoiro E; de Castro-Ríos A; Concheiro M
    J Anal Toxicol; 2022 Oct; 46(8):852-859. PubMed ID: 35748814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonazolam Intoxication Case Report: Danger of Designer Benzodiazepines.
    Moore C; Hammers J; Marshall P
    Am J Forensic Med Pathol; 2022 Dec; 43(4):372-375. PubMed ID: 36281064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alprazolam analogue 4'-chloro deschloroalprazolam identified in seized capsules.
    Trigg S; Wells JM; McGann J; Bock S; Holman A; Harrison SM; Goh CY; Moggach SA; Brown DH
    Drug Test Anal; 2022 Sep; 14(9):1672-1680. PubMed ID: 35666014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues.
    Giorgetti A; Sommer MJ; Wilde M; Perdekamp MG; Auwärter V
    Forensic Toxicol; 2022 Jan; 40(1):180-188. PubMed ID: 36454486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.